CTLA4 and melanoma: The stimulation of the immunological response in melanoma was also obtained by the inhibition of Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), an immunoglobulin cell surface receptor, able to inhibit T-cell activation [25,26].